Literature DB >> 11403990

Cholinergic, noradrenergic, and serotonergic inhibition of fast synaptic transmission in spinal lumbar dorsal horn of rat.

P Li1, M Zhuo.   

Abstract

It is known that spinal nociceptive sensory transmission receives descending inhibitory and facilitatory modulation from supraspinal structures. Glutamate is the major fast excitatory transmitter between primary afferent fibers and spinal dorsal horn neurons. In whole-cell patch clamp recordings from dorsal horn neurons in spinal slices, we investigated synaptic mechanisms for inhibitory modulation at the lumbar level of the spinal cord. Application of the cholinergic receptor agonist carbachol produced a dose-dependent inhibition of glutamate-mediated excitatory postsynaptic currents (EPSCs) (IC(50) 13 microM). Postsynaptic injection of two different types of G-protein inhibitors, guanosine 5'-O-2-thiophosphate or guanosine 5'-O-3-thiotriphosphate, blocked the inhibition produced by carbachol. Clonidine, a selective alpha-adrenergic receptor agonist, also produced a dose-dependent inhibition of EPSCs (IC(50) 7 microM) that was reduced by postsynaptic inhibition of G-proteins. The inhibitory effect of serotonin was likewise mediated by postsynaptic G-proteins. Our results suggest that activation of postsynaptic neurotransmitter receptors plays a critical role in inhibition of glutamate mediated sensory responses by acetylcholine, norepinephrine, and serotonin. Our results support the hypothesis that descending sensory modulation may be mediated by multiple neurotransmitter receptors in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403990     DOI: 10.1016/s0361-9230(01)00470-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

1.  Oxytocin mediates stress-induced analgesia in adult mice.

Authors:  D A Robinson; F Wei; G D Wang; P Li; S J Kim; S K Vogt; L J Muglia; M Zhuo
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

Review 2.  Perioperative pain management.

Authors:  Srinivas Pyati; Tong J Gan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Fos expression in tyrosine hydroxylase-containing neurons in rat brainstem after visceral noxious stimulation: an immunohistochemical study.

Authors:  Feng Han; Yu-Fei Zhang; Yun-Qing Li
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Synaptic input of rat spinal lamina I projection and unidentified neurones in vitro.

Authors:  Anne Dahlhaus; Ruth Ruscheweyh; Jürgen Sandkühler
Journal:  J Physiol       Date:  2005-05-05       Impact factor: 5.182

5.  Selective action of noradrenaline and serotonin on neurones of the spinal superficial dorsal horn in the rat.

Authors:  Yan Lu; Edward R Perl
Journal:  J Physiol       Date:  2007-04-26       Impact factor: 5.182

6.  Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats.

Authors:  R Radhakrishnan; K A Sluka
Journal:  Neuropharmacology       Date:  2003-12       Impact factor: 5.250

7.  Altered patterns of reflex excitability, balance, and locomotion following spinal cord injury and locomotor training.

Authors:  Prodip K Bose; Jiamei Hou; Ronald Parmer; Paul J Reier; Floyd J Thompson
Journal:  Front Physiol       Date:  2012-07-18       Impact factor: 4.566

8.  Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord.

Authors:  Hideaki Ishii; Tatsuro Kohno; Tomohiro Yamakura; Miho Ikoma; Hiroshi Baba
Journal:  Eur J Neurosci       Date:  2008-06-01       Impact factor: 3.386

Review 9.  ALS and oxidative stress: the neurovascular scenario.

Authors:  Akshay Anand; Keshav Thakur; Pawan Kumar Gupta
Journal:  Oxid Med Cell Longev       Date:  2013-12-03       Impact factor: 6.543

10.  Characterization of spinal alpha-adrenergic modulation of nociceptive transmission and hyperalgesia throughout postnatal development in rats.

Authors:  S M Walker; M Fitzgerald
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.